COMP <GO>
PFE vs NVO // REVENUE GROWTH (YOY)
Pfizer Inc. (NYSE) VS. Novo Nordisk A/S (NYSE) • 15-METRIC TALLY: PFE 7
— NVO 4
▲ REVENUE GROWTH (YOY) LEADER: NVO
LAST: $30.52 (+1.90%) • MKT CAP: $170.71B
revenue-growth
-1.60%
LAST: $40.00 (+2.20%) • MKT CAP: $173.31B
revenue-growth
2.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PFE VS. NVO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PFE | NVO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.10% | 9.90% | -4.80 | NVO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.7x | 21.0x | -1.30 | PFE | /valuation <GO> |
| Free Cash Flow Yield | 5.32% | 2.21% | +3.11 | PFE | /fcf-yield <GO> |
| Operating Margin | 15.10% | 13.90% | +1.20 | PFE | /operating-margins <GO> |
| Net Profit Margin | 12.40% | 10.90% | +1.50 | PFE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -1.60% | 2.20% | -3.80 | NVO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.10 | 3.74 | -1.64 | NVO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.5 | 47.9 | +10.60 | PFE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.87 | +0.18 | PFE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.5x | 30.5x | -10.00 | PFE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $170.71B | $173.31B | -$2.60B | NVO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PFE REV | NVO REV | PFE GROSS % | NVO GROSS % | PFE FCF | NVO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $62.58B | — | 74.3% | — | $9.07B | — |
| FY 2024 | $63.63B | — | 71.9% | — | $9.84B | — |
| FY 2023 | $50.91B | — | — | — | $6.41B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PFE // BETA 1.05
NVO // BETA 0.87